NCT01494896View on ClinicalTrials.gov

Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching

TerminatedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Pulmonary Arterial HypertensionChronic Obstructive Pulmonary Disease
Trial Locations (3)

32209

University of Florida, Jacksonville, Jacksonville

32224

Mayo Clinic, Jacksonville

33331

Cleveland Clinic Florida, Weston

Sponsors

Collaborators (1)

United Therapeutics
All Listed Sponsors
collaborator

United Therapeutics

INDUSTRY

lead

University of Florida

OTHER

NCT01494896 - Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching | Biotech Hunter | Biotech Hunter